256 related articles for article (PubMed ID: 21177035)
1. Identifying prescription opioid use disorder in primary care: diagnostic characteristics of the Current Opioid Misuse Measure (COMM).
Meltzer EC; Rybin D; Saitz R; Samet JH; Schwartz SL; Butler SF; Liebschutz JM
Pain; 2011 Feb; 152(2):397-402. PubMed ID: 21177035
[TBL] [Abstract][Full Text] [Related]
2. The utility of a statewide prescription drug-monitoring database vs the Current Opioid Misuse Measure for identifying drug-aberrant behaviors in emergency department patients already on opioids.
Wilson MP; Cucciare MA; Porter A; Chalmers CE; Mullinax S; Mancino M; Oliveto AH
Am J Emerg Med; 2020 Mar; 38(3):503-507. PubMed ID: 31221474
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of the Current Opioid Misuse Measure.
Butler SF; Budman SH; Fernandez KC; Houle B; Benoit C; Katz N; Jamison RN
Pain; 2007 Jul; 130(1-2):144-56. PubMed ID: 17493754
[TBL] [Abstract][Full Text] [Related]
4. Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy.
Butler SF; Budman SH; Fanciullo GJ; Jamison RN
Clin J Pain; 2010; 26(9):770-6. PubMed ID: 20842012
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Detection of Prescription Opioid Misuse and Prescription Opioid Use Disorder Among Emergency Department Patients 50 Years of Age and Older: Performance of the Prescription Drug Use Questionnaire, Patient Version.
Beaudoin FL; Merchant RC; Clark MA
Am J Geriatr Psychiatry; 2016 Aug; 24(8):627-636. PubMed ID: 27426210
[TBL] [Abstract][Full Text] [Related]
6. Detecting aberrant opioid behavior in the emergency department: a prospective study using the screener and Opioid Assessment for Patients with Pain-Revised (SOAPP
Varney SM; Perez CA; Araña AA; Carey KR; Ganem VJ; Zarzabal LA; Ramos RG; Bebarta VS
Intern Emerg Med; 2018 Dec; 13(8):1239-1247. PubMed ID: 29502329
[TBL] [Abstract][Full Text] [Related]
7. Screening in Trauma for Opioid Misuse Prevention (STOMP): Results from a prospective cohort of victims of traumatic injury.
Brown RT; Deyo B; Nicholas C; Baltes A; Hetzel S; Tilhou A; Quanbeck A; Glass J; O'Rourke A; Agarwal S
Drug Alcohol Depend; 2022 Mar; 232():109286. PubMed ID: 35101814
[TBL] [Abstract][Full Text] [Related]
8. Translation and validation of the Chinese version of the Current Opioid Misuse Measure (COMM) for patients with chronic pain in Mainland China.
Zhao Y; Li Y; Zhang X; Lou F
Health Qual Life Outcomes; 2015 Sep; 13():147. PubMed ID: 26374505
[TBL] [Abstract][Full Text] [Related]
9. Should We Use COMM (Current Opioid Misuse Measure) to Screen for Opioid Abuse in Patients With Cancer Pain?
Moryl N; Mendoza TR; Horn SD; Eustaquio JC; Cleeland CS; Inturrisi C
J Natl Compr Canc Netw; 2023 Nov; 21(11):1132-1140.e3. PubMed ID: 37935105
[TBL] [Abstract][Full Text] [Related]
10. Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain.
Wasan AD; Butler SF; Budman SH; Benoit C; Fernandez K; Jamison RN
Clin J Pain; 2007 May; 23(4):307-15. PubMed ID: 17449991
[TBL] [Abstract][Full Text] [Related]
11. Adapting the Current Opioid Misuse Measure (COMM) for people with chronic pain and disability due to arthritis: The development of the COMM 11-PWDA.
Mallery Lankford C; Paez K; Yang M; Lin A
Disabil Health J; 2022 Jun; 15(2S):101296. PubMed ID: 35414483
[TBL] [Abstract][Full Text] [Related]
12. Screening for current opioid misuse and associated risk factors among patients with chronic nonalcoholic pancreatitis pain.
Barth KS; Balliet W; Pelic CM; Madan A; Malcolm R; Adams D; Morgan K; Owczarski S; Borckardt JJ
Pain Med; 2014 Aug; 15(8):1359-64. PubMed ID: 24716629
[TBL] [Abstract][Full Text] [Related]
13. Development of a Brief Version of the Current Opioid Misuse Measure (COMM): The COMM-9.
McCaffrey SA; Black RA; Villapiano AJ; Jamison RN; Butler SF
Pain Med; 2019 Jan; 20(1):113-118. PubMed ID: 29237039
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of the Opioid Compliance Checklist to Monitor Chronic Pain Patients Receiving Opioid Therapy in Primary Care.
Jamison RN; Martel MO; Huang CC; Jurcik D; Edwards RR
J Pain; 2016 Apr; 17(4):414-23. PubMed ID: 26705974
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the current opioid misuse measure among substance use disorder treatment patients.
Ashrafioun L; Bohnert AS; Jannausch M; Ilgen MA
J Subst Abuse Treat; 2015 Aug; 55():15-20. PubMed ID: 25800105
[TBL] [Abstract][Full Text] [Related]
16. Risk of opioid misuse in chronic non-cancer pain in primary care patients - a cross sectional study.
Just JM; Bingener L; Bleckwenn M; Schnakenberg R; Weckbecker K
BMC Fam Pract; 2018 Jun; 19(1):92. PubMed ID: 29925323
[TBL] [Abstract][Full Text] [Related]
17. Systematic review to determine which validated measurement tools can be used to assess risk of problematic analgesic use in patients with chronic pain.
Lawrence R; Mogford D; Colvin L
Br J Anaesth; 2017 Dec; 119(6):1092-1109. PubMed ID: 28981581
[TBL] [Abstract][Full Text] [Related]
18. Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients?
Wasan AD; Butler SF; Budman SH; Fernandez K; Weiss RD; Greenfield SF; Jamison RN
Clin J Pain; 2009; 25(3):193-8. PubMed ID: 19333168
[TBL] [Abstract][Full Text] [Related]
19. Aberrant drug-related behaviors: unsystematic documentation does not identify prescription drug use disorder.
Meltzer EC; Rybin D; Meshesha LZ; Saitz R; Samet JH; Rubens SL; Liebschutz JM
Pain Med; 2012 Nov; 13(11):1436-43. PubMed ID: 23057631
[TBL] [Abstract][Full Text] [Related]
20. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline.
Chou R; Fanciullo GJ; Fine PG; Miaskowski C; Passik SD; Portenoy RK
J Pain; 2009 Feb; 10(2):131-46. PubMed ID: 19187890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
